Seattle Genetics Inc. (NASDAQ:SGEN) went up by 0.12% during the previous trading session, and it is maintaining the win ahead of Tuesday’s trading session. The share price of the Biotechnology giant went up by $171.13 to trade ended Tuesday trading at $170.92. This is up from the $170.92 price recorded on Monday’s trading session. Thanks to this latest performance, SGEN is closer to the higher price 52-week target of $246.00 and further from the lowest price target of $127.00. Its performance from the start of the year has also been positive, with SGEN up by 49.77% year-to-date.
Seattle Genetics Inc. (SGEN) started the day trading at $171.31 and recorded an intraday high of $175.64. It also recorded an intraday low of $170.36 during Tuesday’s trading session. Seattle Genetics Inc. is a very active stock that recorded a trading volume that is less than -36.53% of the average daily trading volume on Tuesday. The stock’s trading volume on Tuesday was 959529, which is less than -36.53 of the total average daily trading volume of 1.31 million.
Seattle Genetics Inc. (NASDAQ:SGEN) 2020 Performance Impressive
The increase in SGEN’s stock price on Tuesday saw its overall performance boost over the past few months. We can quantify the performance of the stock so far this year using a few metrics. The 52-week high price of SGEN currently stands at $173.99, which is higher than the current trading price of the stock by 1.64%. However, SGEN’s current trading price is -171.55% lower than the 52-week low price of $63.02. In terms of trading volume, Seattle Genetics Inc. currently experienced healthy participation during the last trading session. 959529 shares of Seattle Genetics Inc. were traded on the stock exchange on Tuesday, which is less than -36.53% of the 1.31 million average trading volume of the stock.
The performance of the stock has been positive over the past year. SGEN’s performance over the past one year has seen it surge by 142.26%, while the stock has gone up by 45.90% in the last six months. The quarterly performance of SGEN currently stands at 67.99%, and it is up by 9.86% in the last month. The only positive figure was from the weekly performance, which currently reads 9.08%. At the time of writing SGEN’s report, the company has a total market cap of $27.89B, making it one of the largest publicly-traded companies in the world.Seattle Genetics Inc. also has over 1605 employees all over the world.
SGEN Insider Activities
For Seattle Genetics Inc., insiders hold 96.60% of all company shares. The insider transactions over the past six months are down by -66.90%. During that period, insiders bought 335,200 shares in 68 transactions. In that same period, insiders sold 2,667,076 of their shares in 89 transactions. After these transactions, insiders at Seattle Genetics Inc. now hold 1.37M shares, which is over 94.31% of the total company stocks. Institutional investors currently hold a large chunk of the SGEN shares, as they control 0.79% of the company’s total stock.
SGEN Fundamental Analysis
For Seattle Genetics Inc., the stock’s diluted earnings per share (EPS) stands at -1.86. In the coming year, analysts expect the EPS to be -0.77. The stock’s EPS growth this year is 32.10%, -9.20% in the previous five years. In terms of revenue, Seattle Genetics Inc.’s quarterly sales (YOY) is shrinking at -0.62, which is higher than the average annual revenue of -9.20% over the past half a decade.
The Return on Investment (ROI) on Seattle Genetics Inc.’s stock currently stands at -11.80%, and it has a net profit margin of -32.80%. The operating margin of the company is -29.20%, and its gross margin is 93.40%.
SGEN Analysts Prediction
Another analyst that has a Buy rating for SGEN is Needham, which set a price target of between $157 and $163. and H.C. Wainwright reiterate their Buy position on the stock ($140 and $150).
Analysts at Goldman believe that SGEN is Buy, and they have a price target of between $126 and $165. H.C. Wainwright and Goldman also believe that Seattle Genetics Inc.’s stock is outperforming at the moment.
SGEN Technical Analysis
The Simple Moving Average (SMA) is one of the most powerful technical indicators. The 20-day Simple Moving Average of SGEN currently stands at 9.87%, while the SMA50 is 13.16%. The biggest one is the SMA200, which is currently reading 46.99% ahead of Tuesday’s trading session. The Relative Strength Index of this stock is 66.63.
